Studies have demonstrated that the level of PGK1 K131cr in advanced breast cancer cells is significantly lower than that in early-stage cells, suggesting that reduced levels of PGK1 K131cr are associated with a poorer prognosis in breast cancer patients (10). This evidence concerns the gene PGK1 and breast carcinoma.